Thursday, May 26, 2016

JOT101, a product for treatment of Friedreich’s ataxia.

›
Jupiter, Florida (PRWEB) May 25, 2016, by Christer Rosén, Jupiter Orphan Therapeutics. Jupiter Orphan Therapeutics, Inc. (JOT) today anno...
Wednesday, May 25, 2016

Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia

›
Kevin C. Kemp, Amelia J. Cook, Juliana Redondo, Kathreena M. Kurian, Neil J. Scolding and Alastair Wilkins. Acta Neuropathologica Communicat...
Tuesday, May 24, 2016

Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy.

›
Dan Liu, Kai Hu, Peter Nordbeck, Georg Ertl, Stefan Störk and Frank Weidemann. European Journal of Medical Research 201621:21 DOI: 10.1186/s...
Sunday, May 22, 2016

Role of XPD in cellular functions: to TFIIH and beyond

›
Bennett Van Houten, Jochen Kuper, Caroline Kisker, DNA Repair, Available online 16 May 2016, ISSN 1568-7864, doi: 10.1016/j.dnarep.2016.05.0...
Saturday, May 21, 2016

The epidemiology of neuromuscular disorders: Age at onset and gender in the Netherlands

›
Johanna C.W. Deenen, Pieter A. van Doorn, Catharina G. Faber, Anneke J. van der Kooi, Jan B.M. Kuks, Nicolette C. Notermans, Leo H. Visser, ...
Friday, May 20, 2016

Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH

›
18 May 2016 | Marketwired. "Obtaining worldwide rights for interferon gamma-1b solidifies our continued investment in the medicine, a...
Wednesday, May 18, 2016

Movimientos anormales y embarazo / Abnormal movements and pregnancy

›
Eduardo Palacios, Ángela Viviana Navas, Repertorio de Medicina y Cirugía, Available online 30 April 2016, ISSN 0121-7372, doi:10.1016/j.repe...
Tuesday, May 17, 2016

Mitochondrial disorders in children: toward development of small‐molecule treatment strategies

›
Werner JH Koopman, Julien Beyrath, Cheuk‐Wing Fung, Saskia Koene, Richard J Rodenburg, Peter HGM Willems, Jan AM Smeitink. EMBO Molecular Me...
Sunday, May 15, 2016

The Effect of Piracetam on Friedreich Ataxia.

›
Elmal AD , Gündüz A , Uzun N , Apaydn H , Kzltan G; Clinical Neuropharmacology [2016, 39(3):159-160] DOI: 10.1097/WNF.0000000000000148
Friday, May 13, 2016

Can other gene therapy developers avoid Glybera's fate?

›
FiercePharma, by Tracy Staton | May 4, 2016. Glybera, the treatment for an ultra-rare disease called lipoprotein lipase deficiency approv...